Group comparative trial of 2% sodium cromoglycate (Opticrom) with placebo in the treatment of seasonal allergic conjunctivitis
Article first published online: 27 APR 2006
Clinical & Experimental Allergy
Volume 9, Issue 3, pages 271–275, May 1979
How to Cite
LINDSAY-MILLER, A. C. M. (1979), Group comparative trial of 2% sodium cromoglycate (Opticrom) with placebo in the treatment of seasonal allergic conjunctivitis. Clinical & Experimental Allergy, 9: 271–275. doi: 10.1111/j.1365-2222.1979.tb01553.x
- Issue published online: 27 APR 2006
- Article first published online: 27 APR 2006
- (Received 11 October 1978; accepted for publication 13 November 1978)
A double-blind group comparative trial comparing Opticrom with a matching placebo, over a four-week period, in seasonal allergic conjunctivitis is reported. Overall assessment of treatment benefit made at the end of the trial by the patients and the clinician showed a statistically significant difference in favour of Opticrom. Of the patients on Opticrom, eighteen (90%) said they improved while in the clinicians opinion, seventeen (85%) improved.
Six patients using Opticrom and five using placebo complained of stinging of the eyes, while one patient using placebo complained of his eyes becoming bloodshot and watering.